Ageing, Metabolic Dysfunction, and the Therapeutic Role of Antioxidants

Subcell Biochem. 2023:103:341-435. doi: 10.1007/978-3-031-26576-1_15.

Abstract

The gradual ageing of the world population has been accompanied by a dramatic increase in the prevalence of obesity and metabolic diseases, especially type 2 diabetes. The adipose tissue dysfunction associated with ageing and obesity shares many common physiological features, including increased oxidative stress and inflammation. Understanding the mechanisms responsible for adipose tissue dysfunction in obesity may help elucidate the processes that contribute to the metabolic disturbances that occur with ageing. This, in turn, may help identify therapeutic targets for the treatment of obesity and age-related metabolic disorders. Because oxidative stress plays a critical role in these pathological processes, antioxidant dietary interventions could be of therapeutic value for the prevention and/or treatment of age-related diseases and obesity and their complications. In this chapter, we review the molecular and cellular mechanisms by which obesity predisposes individuals to accelerated ageing. Additionally, we critically review the potential of antioxidant dietary interventions to counteract obesity and ageing.

Keywords: Ageing; Dietary interventions; Inflammation; Metabolic syndrome; Nutraceuticals; Obesity; Oxidative stress.

Publication types

  • Review

MeSH terms

  • Aging / pathology
  • Antioxidants* / metabolism
  • Antioxidants* / therapeutic use
  • Diabetes Mellitus, Type 2*
  • Humans
  • Obesity / drug therapy
  • Oxidative Stress

Substances

  • Antioxidants